Embattled commercialisation firm NetScientific is closing two medical diagnostics spinouts from UCLA after both failed to attract external funding.
Commercialisation firm NetScientific is to wind down two of its US-based portfolio companies, Wanda and Vortex Biosciences, both spinouts of University of California, Los Angeles (UCLA) focused on digital health and cancer diagnostics respectively.
The pair were identified as targets for efficiencies in a strategic review published by NetScientific on February 15 on account of them failing to secure external funding to service continued development.
However, NetScientific rejected a preliminary approach for the companies from an unidentified suitor,…
